Inventor · disambiguated record
Parkash Gill
Also filed as: GILL PARKASH · GILL PARKASH S
17 granted patents·18 pending applications·180 citations·filing 1992–2020
93Inventor score
Files withVASGENE THERAPEUTICS INC15UNIV SOUTHERN CALIFORNIA7GILL PARKASH5KRASNOPEROV VALERY4PARKASH S GILL M D INC1
Top patents by PatentIndex Score
35 records- 0194US10851161B2Antibodies that bind cell surface GRP78UNIV SOUTHERN CALIFORNIA·Filed 2019·Granted Dec 1, 2020·6 cites·7 claims
- 0289US6500431B1Inhibitors of angiogenesis and tumor growthUNIV SOUTHERN CALIFORNIA·Filed 1999·Granted Dec 31, 2002·54 cites·39 claims
- 0385US7906116B2Methods for using and identifying modulators of Delta-like 4GILL PARKASH·Filed 2007·Granted Mar 15, 2011·13 cites·6 claims
- 0483US7862816B2Polypeptide compounds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2004·Granted Jan 4, 2011·15 cites·13 claims
- 0579US7381410B2Polypeptide compounds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2004·Granted Jun 3, 2008·6 cites·34 claims
- 0678US7585967B2Nucleic acid compounds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2004·Granted Sep 8, 2009·8 cites·10 claims
- 0773US11845792B2Epitope specific antibodies that bind cell surface GRP78 and their use for cancer detectionUNIV SOUTHERN CALIFORNIA·Filed 2020·Granted Dec 19, 2023·0 cites·7 claims
- 0871US5756537ARegime for paclitaxel in Kaposi's sarcoma patientsPARKASH S GILL M D INC·Filed 1996·Granted May 26, 1998·41 cites·14 claims
- 0966US7341730B1Inhibitors of angiogenesis and tumor growthUNIV SOUTHERN CALIFORNIA·Filed 1999·Granted Mar 11, 2008·12 cites·26 claims
- 1066US2010093831A1Nucleic acid compounds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1165US2010261653A1Polypeptide compounds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1262US2008242840A1Novel inhibitors of angiogenesis and tumor growthUNIV SOUTHERN CALIFORNIA·Filed 2008·Application pending·0 cites
- 1361US8273858B2Polypeptide compounds for inhibiting angiogenesis and tumor growthKRASNOPEROV VALERY·Filed 2008·Granted Sep 25, 2012·0 cites·22 claims
- 1460US9533026B2Polypeptide compounds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2013·Granted Jan 3, 2017·0 cites·7 claims
- 1558US8063183B2Polypeptide compounds for inhibiting angiogenesis and tumor growthKRASNOPEROV VALERY·Filed 2006·Granted Nov 22, 2011·0 cites·28 claims
- 1658US2010330152A1Methods and compositons for antisense vegf oligonucleotidesVASGENE THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1756US2011009323A1Non-immunoglobulin antigen binding scaffolds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 1856US2016185853A1Cancer treatment using antibodies that bind cell surface grp78GILL PARKASH·Filed 2014·Application pending·0 cites
- 1955US8975377B2Cancer treatment using humanized antibodies that bind to EphB4GILL PARKASH·Filed 2008·Granted Mar 10, 2015·0 cites·8 claims
- 2055US2012277162A1Polypeptide compounds for inhibiting angiogenesis and tumor growthKRASNOPEROV VALERY·Filed 2012·Application pending·0 cites
- 2155US2006204512A1Polypeptide compounds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 2253US2011129482A1Polypeptide compounds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 2352US2018094054A1Antibodies that bind cell surface grp78 and their use for detection of cancerGILL PARKASH·Filed 2017·Application pending·0 cites
- 2451US6291667B1Method and composition for treatment of kaposi's sarcomaFiled 1998·Granted Sep 18, 2001·11 cites·12 claims
- 2548US7977463B2Polypeptide compounds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2005·Granted Jul 12, 2011·0 cites·31 claims
- 2648US2006194220A1Compositions and methods for detecting and treating tumorsVASGENE THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 2748US2003096781A1IL-8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcomaUNIV SOUTHERN CALIFORNIA·Filed 2002·Application pending·0 cites
- 2845US2002165174A1Methods and compositions for antisense VEGF oligonucleotidesFiled 2001·Application pending·0 cites
- 2945US2007218061A1Use of ephrinb2 directed agents for the treatment or prevention of viral infectionsVASGENE THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 3045US2012294875A1Non-immunoglobulin antigen binding scaffolds for inhibiting angiogenesis and tumor growthGILL PARKASH·Filed 2012·Application pending·0 cites
- 3144US8981062B2Polypeptide compounds for inhibiting angiogenesis and tumor growthKRASNOPEROV VALERY·Filed 2011·Granted Mar 17, 2015·0 cites·23 claims
- 3243US5763446AUse of pentoxifylline and other tumor necrosis factor blockers for the treatment of aids-associated optic neuropathy and other central nervous system diseasesUNIV SOUTHERN CALIFORNIA·Filed 1992·Granted Jun 9, 1998·14 cites·18 claims
- 3342US2011213127A1Methods for using and identifying modulators of delta-like 4VASGENE THERAPEUTICS INC·Filed 2011·Application pending·0 cites
- 3442US2002026945A1Enhancement of photodynamic therapy by anti-angiogenic treatmentFiled 2001·Application pending·0 cites
- 3538US2007213266A1Methods for using and identifying modulators of Delta-like 4VASGENE THERAPEUTICS INC·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →